← Back to Search

Migraine and Homeostasis:What Can we Learn From Glucose

N/A
Waitlist Available
Led By Alexandra Hovaguimian, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change measure: migraine days and non-migraine days over 3 month period.
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying whether changes in blood sugar levels can trigger migraines or help relieve them. It involves monitoring patients' blood sugar and using food, like luna bars, to see the effects. The goal is to understand if eating or not eating can influence migraine attacks and pain relief.

Eligible Conditions
  • Migraine

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change measure: migraine days and non-migraine days over 3 month period.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change measure: migraine days and non-migraine days over 3 month period. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The difference in blood glucose on days with migraine compared to blood glucose on days without migraine
Secondary study objectives
The is the change in pain score from the time of pain plateau to the pain score at 120 minutes as measured by a visual analogue scale.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Luna Bar InterventionExperimental Treatment1 Intervention
Participants will be asked to monitor their blood sugar during migraine. Study data will also include blood glucose levels, pain severity, 24-hour food diary, 24-hour exercise diary, duration of sleep, perception of quality of sleep, and last menstrual period. This information will be recorded at times when a Luna bar is not consumed, and at times when a Luna Bar is consumed. Participants will serve as their own controls.
Group II: Morning MigraineActive Control1 Intervention
Participants will be asked to monitor their blood sugar on headache free days as well as during migraine. This arm is only for participants who identify as having morning migraine. Study data will also include blood glucose levels, pain severity, 24-hour food diary, 24-hour exercise diary, duration of sleep, perception of quality of sleep, and last menstrual period. Participants will serve as their own controls.

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
859 Previous Clinical Trials
12,932,466 Total Patients Enrolled
3 Trials studying Migraine
72 Patients Enrolled for Migraine
Alexandra Hovaguimian, MDPrincipal Investigator - Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
George Washington University School Of Medical & Hlth Sci (Medical School)
~1 spots leftby Jun 2025